Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine, covering 2023-06-15 to 2023-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine [Phase 2]